000 | 01909 a2200553 4500 | ||
---|---|---|---|
005 | 20250515233942.0 | ||
264 | 0 | _c20100830 | |
008 | 201008s 0 0 eng d | ||
022 | _a1791-7530 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGoda, Takeshi | |
245 | 0 | 0 |
_aBone destruction by invading oral squamous carcinoma cells mediated by the transforming growth factor-beta signalling pathway. _h[electronic resource] |
260 |
_bAnticancer research _cJul 2010 |
||
300 |
_a2615-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xgenetics |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aConnective Tissue Growth Factor _xbiosynthesis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 |
_aGingival Neoplasms _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOsteolysis _xgenetics |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aRANK Ligand _xbiosynthesis |
650 | 0 | 4 | _aReceptor, Transforming Growth Factor-beta Type I |
650 | 0 | 4 |
_aReceptors, Transforming Growth Factor beta _xantagonists & inhibitors |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xantagonists & inhibitors |
650 | 0 | 4 | _aTransplantation, Heterologous |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xbiosynthesis |
700 | 1 | _aShimo, Tsuyoshi | |
700 | 1 | _aYoshihama, Yasuto | |
700 | 1 | _aHassan, Nur Mohammad Monsur | |
700 | 1 | _aIbaragi, Soichiro | |
700 | 1 | _aKurio, Naito | |
700 | 1 | _aOkui, Tatsuo | |
700 | 1 | _aHonami, Tatsuki | |
700 | 1 | _aKishimoto, Koji | |
700 | 1 | _aSasaki, Akira | |
773 | 0 |
_tAnticancer research _gvol. 30 _gno. 7 _gp. 2615-23 |
|
999 |
_c20021886 _d20021886 |